Healthcare | June 12, 2022
Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform
Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions
Subscribe To Our Newsletter & Stay Updated
